HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Co-Diagnostics (CODX) Investors with Significant Losses to Contact Firm’s ...
SAN FRANCISCO, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Co-Diagnostics, Inc. (NASDAQ: CODX) investors who suffered significant losses to submit your losses now. Class Period: May 12, 2022 – Aug. 11, 2022 Lead Plaintiff Deadline: Oct. 17, 2022 …